Skip to content Skip to navigation

Biopharmaceutical

Molecular Insight Pharmaceuticals
Molecular Insight Pharmaceuticals
101 Rogers Street Cambridge, MA 02142 USA

Molecular Insight Pharmaceuticals is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery and development of therapeutic radiopharmaceuticals and targeted molecular imaging agents for use in oncology and cardiology.

Elan Drug Technologies
Elan Drug Technologies
1300 Gould Drive Gainsville, GA 30504 USA

Elan Drug Technologies (EDT) is the world’s leading drug delivery company and is a business unit of Elan (NYSE:ELN). The company focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry. Their NanoCrystal® technology is a proven innovation for poorly water-soluble compounds, manufactured to the nanoscale it has five licensed products commercialized to date.

BioTrove Inc.
BioTrove Inc.
12 Gill Street Woburn, MA 01801 USA

BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications.

Ablynx
Ablynx
Ablynx nv Technologiepark 4 Ghent/Zwijnaarde, 9052 Belgium

Ablynx is focused on the discovery and development of Nanobodies®, a novel class of antibody-derived therapeutic proteins based on single-domain antibody fragments, for a range of serious life-threatening human diseases. Ablynx is developing a portfolio of Nanobody®-based therapeutic programmes in a number of major disease areas, including inflammation, thrombosis, oncology and Alzheimer's disease. The unique structure and stability of Nanobodies® has allowed Ablynx, and its partners, to pursue targets that are typically difficult to reach with conventional antibodies.

Pages